Search

everythinglearnresearchcommunity

for

Search:↓

A man wrongly believed he had parasites, showing that delusional infestation can affect men and is often linked with other psychiatric issues, but can be treated with antipsychotics.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

People with primary immunodeficiencies often have frequent, severe, or unusual infections and may need special tests and management strategies.

Certain medications like α1-blockers, benzodiazepines, and finasteride increase the risk of floppy iris syndrome during cataract surgery.

Skin issues are common in kids with chronic kidney disease.

Testosterone and its byproducts help support male sexual behavior through different pathways in the brain and body.

Uveodermatological syndrome in dogs is hard to manage and can lead to blindness despite treatment.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

Stopping finasteride and closing PFO can help prevent strokes in young adults.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

High doses of finasteride cause cell growth and tumors in mice.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Finasteride improves urinary function in men for 2 years.

Testosterone improves mood and thinking skills; finasteride has no effect.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.